The U.S. Senate approved a bill on Tuesday that would allow for the expansion of scientific research into cannabis and marijuana derivatives including CBD.
Numinus Completes First Extraction of its Psilocybe Mushrooms
VANCOUVER, BC , Dec. 17, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has completed the first legal extraction of Psilocybe mushrooms in Canada by a public company for research and development purposes.
City Of Oakland Urges California To Decriminalize Psychedelics And Allow Healing Ceremonies
The Oakland City Council on Tuesday unanimously approved a resolution that calls on California state lawmakers to enact policies decriminalizing a wide range of psychedelicsand allowing local jurisdictions to permit healing ceremonies where people could use entheogenic substances.
How Psychedelic Drug Stocks Took Off in 2020
After some early turbulence in 2020, psychedelic drug stocks have taken off.
Silver price to rally 30% in 2021 as industrial demand bounces bank - Commerzbank
While gold will continue to attract a lot of attention in 2021 as prices are expected to reach new all-time highs, analysts at Commerzbank are suggesting that investors keep their eyes on silver.
Price gains in gold, silver and bulls have momentum
Gold and silver futures prices are higher in early U.S. trading Wednesday.
Canadian Government Agency Removes Barrier for Psilocybin Therapy
PALM BEACH, Fla., Dec. 16, 2020 /PRNewswire/ -- Health Canada, in a recent "breakthrough Exemption" has quietly expanded its list of who can legally possess and consume psilocybin-containing mushrooms by granting 16 health-care professionals the same exemptions it gave more than a dozen patients with terminal and mental illnesses, according to TheraPsil, a Victoria non-profit that has been behind the struggle to treat a list of mental health issues, including debilitating depression, PTSD and even terminal cancer patients.
Push for Alternative Therapies Prods Researchers Towards Psilocybin
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- The psychedelics market is currently navigating a similar legal situation to the one the cannabis market found itself in for many years.
South Carolina Lawmakers Pre-File Medical Cannabis Reforms for 2021
Lawmakers in South Carolina have pre-filed several cannabis reform measures ahead of the 2021 session: two to legalize medical cannabis, one to decriminalize possession up to one ounce, one allowing some veterans to possess cannabis, and another to hold an “advisory referendum” on broad legalization.
MindMed Upsizes Previously Announced CAD $50m Bought Deal Public Offering
MindMed increases its latest bought-deal financing to CAD$80 million.
Mydecine Innovations Group Engages the ProPharma Group to Proceed with FDA Filings and Approval for Novel Research and Multiple Phase Clinical Trials
DENVER, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced that it has partnered with ProPharma Group, the leading provider of regulatory and compliance services to the pharmaceutical, biotech, and medical device industries.
Feds Announce $350K Grant To Develop Method To Distinguish Hemp And Marijuana
The Department of Justice is issuing a different federal agency a grant to help to develop a method of differentiating hemp and marijuana.
